Target intelligence / Profile preview

Glutathione and protein thiol redox system (Plasmodium) (GSH/Protein-SH system)

Target
GSH/Protein-SH system
Molecular classification
Enzyme, Metabolic pathway, Small molecule
01

Overview

The glutathione and protein thiol system in Plasmodium is a critical metabolic network responsible for maintaining redox equilibrium within the malaria parasite during its development inside host red blood cells. As the parasite consumes host hemoglobin, it releases large quantities of pro-oxidant heme and generates reactive oxygen species (ROS), making a robust antioxidant defense essential for its survival (Müller et al., 2003, PMID: 12831601). Glutathione (GSH) serves as the primary low-molecular-weight thiol that neutralizes ROS and maintains protein thiols in their functional reduced state, a process regulated by enzymes like glutathione reductase (GR) and glutamate-cysteine ligase (GCL) (Sarma et al., 2003, PMID: 12623524). Pharmacological targeting of this system, using agents such as methylene blue or buthionine sulfoximine, disrupts the parasite's ability to manage oxidative stress, leading to cellular damage and death (Becker et al., 2004, PMID: 15121182). While it is a promising therapeutic target, the high degree of similarity between parasite and host redox enzymes poses a significant challenge for achieving drug selectivity and avoiding host toxicity (Luersen et al., 2000, PMID: 10896311).

Other names
Plasmodium glutathione metabolismThiol-based antioxidant system of PlasmodiumGSH/GSSG redox couplePlasmodium falciparum glutathione system
02

Mechanism of action

Inhibition of glutathione-dependent enzymes such as glutathione reductase and glutamate-cysteine ligase, or direct depletion of the reduced glutathione pool, leading to the accumulation of reactive oxygen species and lethal oxidative stress in the parasite.

03

Biological functions

Redox homeostasisAntioxidant defenseDetoxification of reactive oxygen speciesHeme detoxificationProtein folding and repair
04

Disease associations

InfectionMalaria
05

Safety considerations

Risk of hemolytic anemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiencyPotential lack of selectivity between parasite and human host glutathione reductaseInduction of oxidative stress in host erythrocytes
06

Interacting drugs

Methylene blue

4 more in the full profile.

07

Biomarkers

Reduced-to-oxidized glutathione ratio (GSH/GSSG)Protein carbonyl contentParasitemia levelsMalondialdehyde (MDA) levels

Beyond the preview

Go deeper on Glutathione and protein thiol redox system (Plasmodium) (GSH/Protein-SH system).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione and protein thiol redox system (Plasmodium) (GSH/Protein-SH system).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call